Leucine Aminopeptidase to Spleen Length Ratio: A Novel Noninvasive Model for Predicting Esophageal Gastric Variceal Bleeding in Patients With Liver Cirrhosis. | Synapse
March 4, 2026Open Access
Leucine Aminopeptidase to Spleen Length Ratio: A Novel Noninvasive Model for Predicting Esophageal Gastric Variceal Bleeding in Patients With Liver Cirrhosis.
Key Points
To explore the effectiveness of leucine aminopeptidase to spleen length ratio in predicting bleeding risk.
Analyzed leucine aminopeptidase levels and spleen length in patients with liver cirrhosis.
Evaluated the predictive capacity for esophageal gastric variceal bleeding.
Assessed the combination of leucine aminopeptidase ratio and total protein levels.
Leucine aminopeptidase to spleen length ratio showed a significant correlation with bleeding events.
Combination with total protein enhanced predictive accuracy for bleeding in these patients.
Abstract
LSR and the combination application of LSR and TP could help predict bleeding events in patients with EGV.